MeiraGTx Holdings plc (MGTX) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 96.04M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 96.04M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 96.04M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 96.04M | (m) | (m) |
| 2026-03-31 | 92.61M | (m) | (m) |
| 2025-09-30 | 80.49M | (m) | (m) |
| 2025-06-30 | 80.45M | (m) | (m) |
| 2025-03-31 | 80.37M | (m) | (m) |
| 2024-12-31 | 78.85M | (m) | (m) |
| 2024-09-30 | 78.15M | (m) | (m) |
| 2024-06-30 | 64.90M | (m) | (m) |
| 2024-03-31 | 64.31M | (m) | (m) |
| 2023-12-31 | 64.22M | (m) | (m) |
| 2023-09-30 | 63.60M | (m) | (m) |
| 2023-06-30 | 59.54M | (m) | (m) |
| 2023-03-31 | 59.50M | (m) | (m) |
| 2022-12-31 | 48.67M | (m) | (m) |
| 2022-09-30 | 44.73M | (m) | (m) |
| 2022-06-30 | 44.71M | (m) | (m) |
| 2022-03-31 | 44.71M | (m) | (m) |
| 2021-12-31 | 44.68M | (m) | (m) |
| 2021-09-30 | 44.45M | (m) | (m) |
| 2021-06-30 | 44.31M | (m) | (m) |
| 2021-03-31 | 44.28M | (m) | (m) |
| 2020-12-31 | 44.26M | (m) | (m) |
| 2020-09-30 | 38.41M | (m) | (m) |
| 2020-06-30 | 37.36M | (m) | (m) |
| 2020-03-31 | 37.36M | (m) | (m) |
| 2019-09-30 | 36.57M | (m) | (m) |
| 2019-06-30 | 33.37M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |